Lista de obras - Xavier Durando - Dominio Público Uruguay

A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer

artículo científico publicado en 2007

A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)

artículo científico publicado en 2008

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

scientific article published on 26 March 2011

Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer.

artículo científico

Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors

artículo científico publicado en 2012

Aggressive silent GH pituitary tumor resistant to multiple treatments, including temozolomide

artículo científico publicado en 2013

Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas

artículo científico publicado en 2015

Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study.

artículo científico publicado en 2014

Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

artículo científico

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

artículo científico publicado en 2008

Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy

artículo científico publicado en 2007

Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients

scientific article published on 02 May 2009

Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer

artículo científico publicado en 2009

Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.

artículo científico publicado en 2008

Cystemustine in recurrent high grade glioma.

artículo científico publicado en 2006

Determination of irinotecan and SN38 in human plasma by TurboFlow™ liquid chromatography-tandem mass spectrometry

scientific article published on 04 November 2015

Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.

artículo científico publicado en 2010

Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?

scientific article published on 01 February 2010

Does survival increase in metastatic breast cancer with recently available anticancer drugs?

scientific article published on 01 January 2006

Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.

artículo científico publicado en 2015

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

artículo científico publicado en 2014

Hibernoma: a clinical model for exploring the role of brown adipose tissue in the regulation of body weight?

artículo científico publicado en 2013

High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.

artículo científico publicado en 2003

Importance of metabolic changes induced by chemotherapy on prognosis of early‐stage breast cancer patients: a review of potential mechanisms ⬇️

artículo científico publicado el 1 de diciembre de 2011

Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients

artículo científico publicado en 2010

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

scientific article published on 17 August 2011

Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.

artículo científico publicado en 2005

Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer

artículo científico publicado en 2006

Measurement of residual disease after neoadjuvant chemotherapy

artículo científico publicado en 2008

Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients

artículo científico publicado en 2016

Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?

artículo científico publicado en 2009

Methionine dependency and cancer treatment ⬇️

artículo científico publicado el 1 de diciembre de 2003

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.

artículo científico publicado en 2015

Neoadjuvant endocrine therapy in breast cancer

artículo científico publicado en 2005

Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy

artículo científico publicado en 2014

O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.

artículo científico publicado en 2008

Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial

artículo científico publicado en 2008

Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics

artículo científico publicado en 2008

Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer

artículo científico publicado en 2000

Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.

artículo científico publicado en 2012

Prognostic value of initial tumor parameters after metastatic relapse

artículo científico publicado en 2011

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report

artículo científico publicado en 2017

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

artículo científico publicado en 2014

Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial

artículo científico publicado en 2005

Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation

artículo científico publicado en 2008

Temozolomide and unusual indications: review of literature.

artículo científico publicado en 2012

Temozolomide treatment of an adult with a relapsing medulloblastoma.

artículo científico publicado en 2007

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

artículo científico publicado en 2016

Therapeutic drug monitoring and tyrosine kinase inhibitors

artículo científico publicado en 2016

Vaginal Lymphoma: A Possible Cause of Genital Hemorrhage.

artículo científico publicado en 2016

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy

artículo científico publicado en 2012

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GI

artículo científico publicado en 2011

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.

artículo científico publicado en 2010

What is your diagnosis?

artículo científico publicado en 2014

[Elderly patients with glioblastoma: state of the art]

artículo científico publicado en 2015

[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer]

scientific article published on 01 November 2006

[Management of a patient with cancer during all stages of the disease. Symptomatic treatment. Modalities of surveillance. Psychological, ethical and social problems]

artículo científico publicado en 2004

[Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies]

artículo científico publicado en 2013

[Prognostic value of epidermal growth factor receptor]

scientific article published on 01 November 2003

[Therapeutic strategies and systemic treatment of brain melanoma metastases].

artículo científico publicado en 2013

Lista de obras de Xavier Durando

A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer

A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer.

Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors

Aggressive silent GH pituitary tumor resistant to multiple treatments, including temozolomide

Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas

Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study.

Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy

Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients

Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer

Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer.

Cystemustine in recurrent high grade glioma.

Determination of irinotecan and SN38 in human plasma by TurboFlow™ liquid chromatography-tandem mass spectrometry

Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.

Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?

Does survival increase in metastatic breast cancer with recently available anticancer drugs?

Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

Hibernoma: a clinical model for exploring the role of brown adipose tissue in the regulation of body weight?

High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.

Importance of metabolic changes induced by chemotherapy on prognosis of early‐stage breast cancer patients: a review of potential mechanisms ⬇️

Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.

Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer

Measurement of residual disease after neoadjuvant chemotherapy

Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients

Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?

Methionine dependency and cancer treatment ⬇️

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.

Neoadjuvant endocrine therapy in breast cancer

Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy

O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.

Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial

Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics

Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer

Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.

Prognostic value of initial tumor parameters after metastatic relapse

Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial

Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation

Temozolomide and unusual indications: review of literature.

Temozolomide treatment of an adult with a relapsing medulloblastoma.

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

Therapeutic drug monitoring and tyrosine kinase inhibitors

Vaginal Lymphoma: A Possible Cause of Genital Hemorrhage.

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GI

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.

What is your diagnosis?

[Elderly patients with glioblastoma: state of the art]

[Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer]

[Management of a patient with cancer during all stages of the disease. Symptomatic treatment. Modalities of surveillance. Psychological, ethical and social problems]

[Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies]

[Prognostic value of epidermal growth factor receptor]

[Therapeutic strategies and systemic treatment of brain melanoma metastases].